AAAAAA

   
Results: 1-15 |
Results: 15
IN-VITRO ACTIVITY, ANTITUMOR EFFICACY AND PHARMACOKINETICS OF INDOLIN-2-ONE VEGF RECEPTOR INHIBITORS
Authors: SHAWVER LK ANTONIAN L SUN L TANG C WAGNER GS MCMAHON G FONG TAT SUKBUNTHERNG J
Citation: Lk. Shawver et al., IN-VITRO ACTIVITY, ANTITUMOR EFFICACY AND PHARMACOKINETICS OF INDOLIN-2-ONE VEGF RECEPTOR INHIBITORS, Annals of oncology, 9, 1998, pp. 289-289
SU101, AND NOT ITS MAJOR METABOLITE, INHIBITS PDGF-DEPENDENT RECEPTORTYROSINE PHOSPHORYLATION, CELL-CYCLE PROGRESSION, AND HUMAN TUMOR-CELL GROWTH
Authors: LIPSON KE WANG X CHEN H SUTTON B WEST KA CHU L TANG C STRAWN LM POWELL TJ HIRTH KP SHAWVER LK MCMAHON G
Citation: Ke. Lipson et al., SU101, AND NOT ITS MAJOR METABOLITE, INHIBITS PDGF-DEPENDENT RECEPTORTYROSINE PHOSPHORYLATION, CELL-CYCLE PROGRESSION, AND HUMAN TUMOR-CELL GROWTH, Annals of oncology, 9, 1998, pp. 423-423
RECEPTOR TYROSINE KINASES AS TARGETS FOR INHIBITION OF ANGIOGENESIS
Authors: SHAWVER LK LIPSON KE FONG TAT MCMAHON G PLOWMAN GD STRAWN LM
Citation: Lk. Shawver et al., RECEPTOR TYROSINE KINASES AS TARGETS FOR INHIBITION OF ANGIOGENESIS, Drug discovery today, 2(2), 1997, pp. 50-63
INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-MEDIATED SIGNAL-TRANSDUCTION AND TUMOR-GROWTH BY N-[4-(TRIFLUOROMETHYL)-PHENYL] 5-METHYLISOXAZOLE-4-CARBOXAMIDE
Authors: SHAWVER LK SCHWARTZ DP MANN E CHEN H TSAI JM CHU L TAYLORSON L LONGHI M MEREDITH S GERMAIN L JACOBS JS TANG C ULLRICH A BERENS ME HERSH E MCMAHON G HIRTH KP
Citation: Lk. Shawver et al., INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-MEDIATED SIGNAL-TRANSDUCTION AND TUMOR-GROWTH BY N-[4-(TRIFLUOROMETHYL)-PHENYL] 5-METHYLISOXAZOLE-4-CARBOXAMIDE, Clinical cancer research, 3(7), 1997, pp. 1167-1177
UNLIGANDED EPIDERMAL GROWTH-FACTOR RECEPTOR DIMERIZATION INDUCED BY DIRECT INTERACTION OF QUINAZOLINES WITH THE ATP BINDING-SITE
Authors: ARTEAGA CL RAMSEY TT SHAWVER LK GUYER CA
Citation: Cl. Arteaga et al., UNLIGANDED EPIDERMAL GROWTH-FACTOR RECEPTOR DIMERIZATION INDUCED BY DIRECT INTERACTION OF QUINAZOLINES WITH THE ATP BINDING-SITE, The Journal of biological chemistry, 272(37), 1997, pp. 23247-23254
DOMINANT-NEGATIVE INHIBITION OF FLK-1 SUPPRESSES THE GROWTH OF MANY TUMOR TYPES IN-VIVO
Authors: MILLAUER B LONGHI MP PLATE KH SHAWVER LK RISAU W ULLRICH A STRAWN LM
Citation: B. Millauer et al., DOMINANT-NEGATIVE INHIBITION OF FLK-1 SUPPRESSES THE GROWTH OF MANY TUMOR TYPES IN-VIVO, Cancer research, 56(7), 1996, pp. 1615-1620
FLK-1 AS A TARGET FOR TUMOR-GROWTH INHIBITION
Authors: STRAWN LM MCMAHON G APP H SCHRECK R KUCHLER WR LONGHI MP HUI TH TANG C LEVITZKI A GAZIT A CHEN I KERI G ORFI L RISAU W FLAMME I ULLRICH A HIRTH KP SHAWVER LK
Citation: Lm. Strawn et al., FLK-1 AS A TARGET FOR TUMOR-GROWTH INHIBITION, Cancer research, 56(15), 1996, pp. 3540-3545
A TUMOR-DERIVED PROTEIN WHICH PROVIDES T-CELL COSTIMULATION THROUGH ACCESSORY CELL ACTIVATION
Authors: POWELL TJ SCHRECK R MCCALL M HUI T RICE A APP H AZAM M ULLRICH A SHAWVER LK
Citation: Tj. Powell et al., A TUMOR-DERIVED PROTEIN WHICH PROVIDES T-CELL COSTIMULATION THROUGH ACCESSORY CELL ACTIVATION, Journal of immunotherapy with emphasis on tumor immunology, 17(4), 1995, pp. 209-221
MEMBRANE-BOUND RECEPTOR TYROSINE KINASES AND CHEMICAL CARCINOGENESIS
Authors: SHAWVER LK STRAWN LM ULLRICH A
Citation: Lk. Shawver et al., MEMBRANE-BOUND RECEPTOR TYROSINE KINASES AND CHEMICAL CARCINOGENESIS, Mutation research, 333(1-2), 1995, pp. 23-28
CONSTRUCTION OF A CHIMERIC ANTIBODY WITH THERAPEUTIC POTENTIAL FOR CANCERS WHICH OVEREXPRESS C-ERBB-2
Authors: LIU HLC PARKES DL LANGTON BC XUAN JA LONGHI M ELLIGER SS CHAO LA MCGROGAN MP BRANDIS JW SHAWVER LK
Citation: Hlc. Liu et al., CONSTRUCTION OF A CHIMERIC ANTIBODY WITH THERAPEUTIC POTENTIAL FOR CANCERS WHICH OVEREXPRESS C-ERBB-2, Biochemical and biophysical research communications, 211(3), 1995, pp. 792-803
GLIOBLASTOMA GROWTH INHIBITED IN-VIVO BY A DOMINANT-NEGATIVE FLK-1 MUTANT
Authors: MILLAUER B SHAWVER LK PLATE KH RISAU W ULLRICH A
Citation: B. Millauer et al., GLIOBLASTOMA GROWTH INHIBITED IN-VIVO BY A DOMINANT-NEGATIVE FLK-1 MUTANT, Nature, 367(6463), 1994, pp. 576-579
INHIBITION OF GLIOMA CELL-GROWTH BY A TRUNCATED PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR
Authors: STRAWN LM MANN E ELLIGER SS CHU LM GERMAIN LL NIEDERFELLNER G ULLRICH A SHAWVER LK
Citation: Lm. Strawn et al., INHIBITION OF GLIOMA CELL-GROWTH BY A TRUNCATED PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR, The Journal of biological chemistry, 269(33), 1994, pp. 21215-21222
THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR
Authors: ULLRICH A SURES I DEGIDIO M JALLAL B POWELL TJ HERBST R DREPS A AZAM M RUBINSTEIN M NATOLI C SHAWVER LK SCHLESSINGER J IACOBELLI S
Citation: A. Ullrich et al., THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR, The Journal of biological chemistry, 269(28), 1994, pp. 18401-18407
LIGAND-LIKE EFFECTS INDUCED BY ANTI-C-ERBB-2 ANTIBODIES DO NOT CORRELATE WITH AND ARE NOT REQUIRED FOR GROWTH-INHIBITION OF HUMAN CARCINOMA-CELLS
Authors: SHAWVER LK MANN E ELLIGER SS DUGGER TC ARTEAGA CL
Citation: Lk. Shawver et al., LIGAND-LIKE EFFECTS INDUCED BY ANTI-C-ERBB-2 ANTIBODIES DO NOT CORRELATE WITH AND ARE NOT REQUIRED FOR GROWTH-INHIBITION OF HUMAN CARCINOMA-CELLS, Cancer research, 54(5), 1994, pp. 1367-1373
P185(C-ERBB-2) SIGNALING ENHANCES CISPLATIN-INDUCED CYTOTOXICITY IN HUMAN BREAST-CARCINOMA CELLS - ASSOCIATION BETWEEN AN ONCOGENIC RECEPTOR TYROSINE KINASE AND DRUG-INDUCED DNA-REPAIR
Authors: ARTEAGA CL WINNIER AR POIRIER MC LOPEZLARRAZA DM SHAWVER LK HURD SD STEWART SJ
Citation: Cl. Arteaga et al., P185(C-ERBB-2) SIGNALING ENHANCES CISPLATIN-INDUCED CYTOTOXICITY IN HUMAN BREAST-CARCINOMA CELLS - ASSOCIATION BETWEEN AN ONCOGENIC RECEPTOR TYROSINE KINASE AND DRUG-INDUCED DNA-REPAIR, Cancer research, 54(14), 1994, pp. 3758-3765
Risultati: 1-15 |